Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 4
1976 2
1977 1
1978 1
1979 1
1980 1
1982 1
1985 2
1987 2
1988 1
1989 1
1991 2
1992 1
1993 3
1994 3
1995 2
1996 2
1997 4
1998 1
1999 2
2000 1
2001 2
2003 2
2004 2
2005 2
2007 2
2008 4
2009 2
2010 3
2011 1
2013 4
2015 2
2016 3
2017 2
2018 3
2019 1
2020 3
2021 1
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Current Management of Childhood Acute Myeloid Leukemia.
Rubnitz JE. Rubnitz JE. Paediatr Drugs. 2017 Feb;19(1):1-10. doi: 10.1007/s40272-016-0200-6. Paediatr Drugs. 2017. PMID: 27785777 Review.
The outcome for children with acute myeloid leukemia (AML) has improved significantly over the past 30 years, with complete remission and overall survival rates exceeding 90 and 60%, respectively, in recent clinical trials. ...Nevertheless, novel th …
The outcome for children with acute myeloid leukemia (AML) has improved significantly over the past 30 years, with comp …
Treatment of Childhood Acute Myeloid Leukemia in Bulgaria.
Burnusuzov HA, Yordanova MN, Avramova BE, Yurukova NN, Bachvarov KN, Muchinova AB, Vlahova IH, Stoyanova AA, Mumdzhiev IN, Ivanova LR, Spasov NY, Peteva ET, Belcheva MI, Hristozova H, Spasova MI, Kaleva VI, Bobev D, Konstantinov DN. Burnusuzov HA, et al. Folia Med (Plovdiv). 2018 Jun 1;60(2):234-240. doi: 10.1515/folmed-2017-0090. Folia Med (Plovdiv). 2018. PMID: 30355812
BACKGROUND: During the last four decades the prognosis of childhood acute myeloid leukemia (AML) has been substantially improved due to an increase in complete remission (CR) rates, event-free survival (EFS) and reduced early mortality. The rela …
BACKGROUND: During the last four decades the prognosis of childhood acute myeloid leukemia (AML) has been substa …
Molecular diagnostics in the treatment of leukemia.
Rubnitz JE, Pui CH. Rubnitz JE, et al. Curr Opin Hematol. 1999 Jul;6(4):229-35. doi: 10.1097/00062752-199907000-00006. Curr Opin Hematol. 1999. PMID: 10400371 Review.
The molecular characterization of childhood leukemias directly affects our treatment strategies. Acute lymphoblastic leukemia patients with the TEL-AML1 fusion have a favorable prognosis, whereas those with the E2A-PBX1 fusion require more intensive therap …
The molecular characterization of childhood leukemias directly affects our treatment strategies. Acute lymphoblastic leukem …
Treatment of childhood acute nonlymphoblastic leukemia: a review.
Boulad F, Kernan NA. Boulad F, et al. Cancer Invest. 1993;11(5):534-53. doi: 10.3109/07357909309011672. Cancer Invest. 1993. PMID: 8402223 Review.
So far, all the pediatric trials that have tried to shorten the maintenance therapy of this disease were able to do so without jeopardizing the final outcome. The final optimal minimal duration of therapy has yet to be established. The best therapy for a pati …
So far, all the pediatric trials that have tried to shorten the maintenance therapy of this disease were able to do so without jeopar …
Treatment of childhood acute myeloid leukemia.
ter Bals E, Kaspers GJ. ter Bals E, et al. Expert Rev Anticancer Ther. 2005 Oct;5(5):917-29. doi: 10.1586/14737140.5.5.917. Expert Rev Anticancer Ther. 2005. PMID: 16221060 Review.
Childhood acute myeloid leukemia is rare, but accounts for a significant number of malignancy-related deaths in this age group. ...In addition to tailoring therapy according to biologic features and especially monitoring treatment by measurement …
Childhood acute myeloid leukemia is rare, but accounts for a significant number of malignancy-related deaths in …
Place of HSCT in treatment of childhood AML.
Klingebiel T, Reinhardt D, Bader P; EBMT Paediatric Diseases Working Party. Klingebiel T, et al. Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S7-9. doi: 10.1038/bmt.2008.276. Bone Marrow Transplant. 2008. PMID: 18978749 Review.
This short review focuses on the role of hematopoietic SCT (HSCT) in childhood AML. In first CR (CR1), some studies demonstrate superiority of allogeneic HSCT with HLA identical sibling donors over the continuation of chemotherapy and others did not. ...However, published …
This short review focuses on the role of hematopoietic SCT (HSCT) in childhood AML. In first CR (CR1), some studies demonstrate super …
Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review.
Hasle H, Kaspers GJ. Hasle H, et al. Br J Haematol. 2017 Jan;176(2):168-178. doi: 10.1111/bjh.14419. Epub 2016 Oct 21. Br J Haematol. 2017. PMID: 27766626 Free article. Review.
Over the last four decades the survival of paediatric patients with acute myeloid leukaemia has gradually increased to 70% in high-income countries. The therapy is very intensive and associated with many acute and long-term side effects. ...
Over the last four decades the survival of paediatric patients with acute myeloid leukaemia has gradually increased to 70% in …
Diagnosis and treatment of childhood acute myelogenous leukemia.
Ebb DH, Weinstein HJ. Ebb DH, et al. Pediatr Clin North Am. 1997 Aug;44(4):847-62. doi: 10.1016/s0031-3955(05)70533-2. Pediatr Clin North Am. 1997. PMID: 9286288 Review.
Acute myelogenous leukemia (AML) accounts for about 20% of the acute leukemias seen in children. In contrast to childhood acute lymphoblastic leukemia (ALL), there has only been a modest improvement in the cure rate of children with AML d …
Acute myelogenous leukemia (AML) accounts for about 20% of the acute leukemias seen in children. In contrast to chil …
Development of a curative treatment within the AML-BFM studies.
Creutzig U, Zimmermann M, Dworzak MN, Ritter J, Schellong G, Reinhardt D. Creutzig U, et al. Klin Padiatr. 2013 May;225 Suppl 1:S79-86. doi: 10.1055/s-0033-1337968. Epub 2013 May 22. Klin Padiatr. 2013. PMID: 23700063 Review.
The first multicenter treatment study for AML in childhood in Germany was performed from 1978 onwards. The therapy plan was designed similar to that for the acute lymphoblastic leukaemia (ALL). The drugs with the highest efficacy in AML, cytarabine cutting ca …
The first multicenter treatment study for AML in childhood in Germany was performed from 1978 onwards. The therapy plan was de …
Recent advances in management of acute myeloid leukemia (AML).
Shah M, Agarwal B. Shah M, et al. Indian J Pediatr. 2008 Aug;75(8):831-7. doi: 10.1007/s12098-008-0155-x. Epub 2008 Sep 4. Indian J Pediatr. 2008. PMID: 18769895 Review.
Acute myeloid leukemia (AML) is the most common childhood malignancy. AML has therapeutically been difficult to treat. In 2001, the World Health Organization (WHO), in conjunction with the Society for Hematopathology and the European Association …
Acute myeloid leukemia (AML) is the most common childhood malignancy. AML has therapeutically been diffic …
76 results